| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V3885 | Ivosidenib (AG-120) racemate | 1448346-63-1 | Ivosidenib racemate (AG120; RG120; AG-120; RG-120;Tibsovo), the racemic mixture ofIvosidenib, is an orally bioavailable andsmall moleculeIDH1 inhibitor that inhibits mutated cytosolic isocitrate dehydrogenase 1 (IDH1). |
|
V0856 | MK-8245 | 1030612-90-8 | MK-8245 (MK8245; MK 8245) is a novel and potentliver-targeted inhibitor of stearoyl-CoA desaturase (SCD) with anti-diabetic and anti-dyslipidemic activities. |
|
V124938 | 3-(2',5'-Disulfophenylimino)-3H-phenothiazine sodium | 1419158-69-2 | 3-(2',5'-Disulfophenylimino)-3H-phenothiazine sodium is an electron transfer mediator. |
|
V3151 | 3-Methylpyrazole | 1453-58-3 | 3-Methylpyrazole (also known as 3-MP) is a weak inhibitor ofalcohol dehydrogenase,which are a group of dehydrogenase enzymes that occur in many organisms and facilitate the interconversion between alcohols and aldehydes or ketones with the reduction of nicotinamide adenine dinucleotide (NAD+ to NADH). |
|
V128171 | AChE-IN-85 | AChE-IN-85 is an acetylcholinesterase inhibitor with an IC50 value of 0.083 μM. | |
|
V0855 | AGI-5198 | 1355326-35-0 | AGI-5198 (also know as IDH-C35; IDHC35; AGI-5198; AGI 5198) is a novel, highly potent and selective inhibitor of IDH1 (isocitrate dehydrogenase 1) R132H/R132C mutants with potential anticancer activity. |
|
V0862 | AGI-6780 | 1432660-47-3 | AGI-6780 (AGI6780; AGI 6780) is a potent and selective inhibitor oftumor-associated mutant IDH2 (isocitrate dehydrogenases 2) R140Q with potential anti-inflammatory activity. |
|
V128917 | Antibacterial agent 325 | Antibacterial agent 325 is an antibacterial agent. | |
|
V128922 | Antibacterial agent 330 | 3031427-16-1 | Antibacterial agent 330 is an antibacterial agent. |
|
V11730 | ASP9521 | 1126084-37-4 | ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3). |
|
V4174 | BAY-1436032 | 1803274-65-8 | BAY-1436032 is a novel and potent pan-mutant isocitrate dehydrogenase 1 (IDH1) inhibitor both in vitro and in vivo. |
|
V16006 | BVT-2733 | 376640-41-4 | BVT-2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, which attenuates obesity and inflammation in diet-induced obese mice. |
|
V18887 | CVT-10216 | 1005334-57-5 | CVT-10216, an isoflavone compound, is a novel, highly potent and selective, reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2) with IC50s of 29 and 1300 nM for ALDH2 and ALDH1, respectively. |
|
V39998 | DHODH-IN-11 | 1263303-95-2 | DHODH-IN-11 (Compound 14b) is a Leflunomide analogue and a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with a pKa of 5.03. |
|
V133650 | DHODH-IN-28 | DHODH-IN-28 is a potent fluorescent inhibitor that targets human dihydroorotate dehydrogenase (hDHODH) with an IC50 value of 170 nM. | |
|
V134380 | DSM1465 | 3109381-06-5 | DSM1465 is a potent and selective inhibitor of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) with an IC50 value of 15 nM and an EC50 value of 1.4 nM against Plasmodium falciparum 3D7 (Pf3D7) parasite. |
|
V136119 | Flubeneteram | 1676101-39-5 | Flubeneteram is a succinate dehydrogenase inhibitor with an IC50 value of 0.0484 μM. |
|
V138128 | Isofetamid | 875915-78-9 | Isofetamid is a succinate dehydrogenase inhibitor and bactericide. |
|
V139549 | MDH2-IN-2 | 3047410-41-0 | MDH2-IN-2 is an orally effective MDH2 inhibitor with an IC50 value of 5.9 μM. |
|
V139594 | MEDS700 | 2770979-81-0 | MEDS700 is a blood-brain barrier-permeable human dihydroorotate dehydrogenase (hDHODH) inhibitor with an IC50 value of 1.5 nM. |